Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
30%(3 trials)

Phase Distribution

Ph phase_1
3
23%
Ph phase_2
2
15%
Ph not_applicable
8
62%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
3(23.1%)
Phase 2Efficacy & side effects
2(15.4%)
N/ANon-phased studies
8(61.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(10)
Other(1)

Detailed Status

Completed10
Recruiting1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (23.1%)
Phase 22 (15.4%)
N/A8 (61.5%)

Trials by Status

recruiting18%
completed1077%
unknown18%
not_yet_recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
13